Correction: Clinical utility of combinatorial pharmacogenomic testing in depression: A Canadian patient- and rater-blinded, randomized, controlled trial

• Arun K. Tiwari,
• Clement C. Zai,
• C. Anthony Altar,
• Julie-Anne Tanner,
• Paige E. Davies,
• Paul Traxler,
• James Li,
• Elizabeth S. Cogan,
• Matthew T. Kucera,
• Ana Gugila,
• Nicole Braganza,
• Heather Emmerson,
• Gwyneth Zai,
• Daniel J. Müller,
• Robert Levitan,
• Stefan Kloiber,
• Zafiris J. Daskalakis,
• Benicio N. Frey,
• James M. Bowen,
• Jean-Eric Tarride,
• Richard Tytus,
• Ranjith Chandrasena,
• Nicholas Voudouris,
• Valerie H. Taylor,
• Raymond Tempier,
• Verinder Sharma,
• Akshya Vasudev,
• Peter Dzongowski,
• Lew Pliamm,
• Todd Greenspoon,
• Bryan M. Dechairo,
• James L. Kennedy

Affiliations

Arun K. Tiwari

Tanenbaum Centre for Pharmacogenetics, Neurogenetics Section, Molecular Brain Sciences Research Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health

Clement C. Zai

Tanenbaum Centre for Pharmacogenetics, Neurogenetics Section, Molecular Brain Sciences Research Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health

C. Anthony Altar

Splice Therapeutics, 20271 Goldenrod Lane, Lab 2071

Julie-Anne Tanner

Myriad Neuroscience

Paige E. Davies

Myriad Neuroscience

Paul Traxler

Myriad Neuroscience

James Li

Myriad Neuroscience

Elizabeth S. Cogan

Myriad Genetics

Matthew T. Kucera

Myriad Genetics

Ana Gugila

Myriad Neuroscience

Nicole Braganza

Tanenbaum Centre for Pharmacogenetics, Neurogenetics Section, Molecular Brain Sciences Research Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health

Heather Emmerson

Tanenbaum Centre for Pharmacogenetics, Neurogenetics Section, Molecular Brain Sciences Research Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health

Gwyneth Zai

Tanenbaum Centre for Pharmacogenetics, Neurogenetics Section, Molecular Brain Sciences Research Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health

Daniel J. Müller

Tanenbaum Centre for Pharmacogenetics, Neurogenetics Section, Molecular Brain Sciences Research Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health

Robert Levitan

Tanenbaum Centre for Pharmacogenetics, Neurogenetics Section, Molecular Brain Sciences Research Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health

Stefan Kloiber

Department of Psychiatry, University of Toronto

Zafiris J. Daskalakis

Department of Psychiatry, UC San Diego

Benicio N. Frey

Mood Disorders Treatment and Research Centre and Women’s Health Concerns Clinic, St Joseph’s Healthcare Hamilton

James M. Bowen

Department of Health Research Methods, Evidence and Impact, Faculty of Health Sciences, McMaster University

Jean-Eric Tarride

Department of Health Research Methods, Evidence, and Impact (HEI), Faculty of Health Science, McMaster University

Richard Tytus

Family Medicine, McMaster University

Ranjith Chandrasena

Chatham-Kent Health Alliance

Nicholas Voudouris

Thornhill Medical Center

Valerie H. Taylor

Department of Psychiatry, University of Calgary, Hotchkiss Brain Institute, an Institute of the Cumming School of Medicine

Raymond Tempier

Hôpital Montfort

Verinder Sharma

Department of Psychiatry, Western University

Akshya Vasudev

Department of Psychiatry, Geriatric Psychiatry and Neurosciences, Western University

Peter Dzongowski

Milestone Research

Lew Pliamm

Canadian Phase Onward Inc., Polyclinic Family and Specialty Medicine Facility, Polyclinic Family Health Group

Todd Greenspoon

Hamilton Community Health Centre

Bryan M. Dechairo

Myriad Genetics

James L. Kennedy

Tanenbaum Centre for Pharmacogenetics, Neurogenetics Section, Molecular Brain Sciences Research Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health